AI 90日予測
購入
7日間
30日
90日
AI信頼度: 9% スピアマン相関
5月 22, 2026
価格チャート
チャートを読み込み中...
主要統計
時価総額
$843M
PER（株価収益率）
7.4x
PBR（株価純資産倍率）
2.90x
収益
$109M
流動比率
13.14x
について Theravance Biopharma, Inc.
Theravance Biopharma, Inc. (TBPH) Life Sciencesセクターで事業を展開、具体的にはPharmaceutical Preparations業界内で. .
We do not have any company description for Theravance Biopharma, Inc. at the moment.
最新ニュース
Pharmaceutical Preparations 同業他社
| 企業 | ティッカー | AIシグナル | 時価総額 | P/E |
|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | AARD | ██% | $99M | -x |
| Abbvie Inc. | ABBV | ██% | $381.90B | 105.1x |
| Abcellera Biologics Inc. | ABCL | ██% | $1.58B | -x |
| Abeona Therapeutics Inc. | ABEO | ██% | $309M | 4.7x |
| Abbott Laboratories | ABT | ██% | $152.25B | 24.3x |
| Arbutus Biopharma Corp | ABUS | ██% | $857M | 5.3x |
| Abvc Biopharma, Inc. | ABVC | ██% | $29M | -x |
| Abivax S.A. | ABVX | ██% | $9.58B | -x |
| Acadia Pharmaceuticals Inc | ACAD | ██% | $3.61B | 9.6x |
| Adicet Bio, Inc. | ACET | ██% | $78M | -x |
| Aclaris Therapeutics, Inc. | ACRS | ██% | $631M | -x |
| Acrivon Therapeutics, Inc. | ACRV | ██% | $68M | -x |
| Actuate Therapeutics, Inc. | ACTU | ██% | $120M | -x |
| Accustem Sciences Inc. | ACUT | ██% | $4M | -x |
| Acurx Pharmaceuticals, Inc. | ACXP | ██% | $8M | -x |
| Adagene Inc. | ADAG | ██% | $248M | -x |
| Adc Therapeutics Sa | ADCT | ██% | $431M | -x |
| Adial Pharmaceuticals, Inc. | ADIL | ██% | $4M | -x |
| Aditxt, Inc. | ADTX | ██% | $260K | -x |
| Addex Therapeutics Ltd. | ADXN | ██% | $9M | -x |
| Aeon Biopharma, Inc. | AEON | ██% | $20M | -x |
| Agios Pharmaceuticals, Inc. | AGIO | ██% | $1.67B | -x |
| Akebia Therapeutics, Inc. | AKBA | ██% | $273M | -x |
| Akero Therapeutics, Inc. | AKRO | ██% | $4.38B | -8.7x |
| Akari Therapeutics Plc | AKTX | ██% | $21M | -x |
| Aldeyra Therapeutics, Inc. | ALDX | ██% | $94M | -x |
| Alkermes Plc. | ALKS | ██% | $6.13B | 40.1x |
| Allarity Therapeutics, Inc. | ALLR | ██% | $28M | -x |
| Alumis Inc. | ALMS | ██% | $2.75B | -x |
| Alnylam Pharmaceuticals, Inc. | ALNY | ██% | $39.38B | 125.5x |
| Altimmune, Inc. | ALT | ██% | $564M | -x |
| Alx Oncology Holdings … | ALXO | ██% | $266M | -x |
| Alzamend Neuro, Inc. | ALZN | ██% | $4M | -x |
| Amylyx Pharmaceuticals, Inc. | AMLX | ██% | $1.51B | -x |
| Amphastar Pharmaceuticals, Inc. | AMPH | ██% | $822M | 10.4x |
| Amarin Corp Plc\Uk | AMRN | ██% | $303M | -x |
| Amneal Pharmaceuticals, Inc. | AMRX | ██% | $3.93B | 32.1x |
| Anaptysbio, Inc | ANAB | ██% | $1.73B | -x |
| Anebulo Pharmaceuticals, Inc. | ANEB | ██% | $19M | -x |
| Ani Pharmaceuticals Inc | ANIP | ██% | $1.73B | 18.8x |
| Anixa Biosciences Inc | ANIX | ██% | $93M | -x |
| Annexon, Inc. | ANNX | ██% | $809M | -x |
| Alto Neuroscience, Inc. | ANRO | ██% | $744M | -x |
| An2 Therapeutics, Inc. | ANTX | ██% | $175M | -x |
| Annovis Bio, Inc. | ANVS | ██% | $95M | -x |
| Apollomics Inc. | APLM | ██% | $31M | -x |
| Apellis Pharmaceuticals, Inc. | APLS | ██% | $5.25B | 39.4x |
| Applied Therapeutics, Inc. | APLT | ██% | $15M | -0.7x |
| Aprea Therapeutics, Inc. | APRE | ██% | $11M | -x |
| Apimeds Pharmaceuticals Us, … | APUS | ██% | $19M | -x |
| Aptevo Therapeutics Inc. | APVO | ██% | $6M | -x |
| Aquestive Therapeutics, Inc. | AQST | ██% | $512M | -x |
| Arcturus Therapeutics Holdings … | ARCT | ██% | $200M | -x |
| Ardelyx, Inc. | ARDX | ██% | $1.51B | -x |
| Arcutis Biotherapeutics, Inc. | ARQT | ██% | $2.61B | -x |
| Artelo Biosciences, Inc. | ARTL | ██% | $3M | -x |
| Arvinas, Inc. | ARVN | ██% | $586M | -x |
| Arrowhead Pharmaceuticals, Inc. | ARWR | ██% | $10.54B | -x |
| Aspire Biopharma Holdings, … | ASBP | ██% | $7M | -x |
| Assembly Biosciences, Inc. | ASMB | ██% | $450M | -x |
| Ascendis Pharma A/S | ASND | ██% | $15.31B | -x |
| Assertio Holdings, Inc. | ASRT | ██% | $151M | -x |
| Atai Beckley N.V. | ATAI | ██% | $1.59B | -x |
| Alterity Therapeutics Ltd | ATHE | ██% | $78M | -x |
| Actinium Pharmaceuticals, Inc. | ATNM | ██% | $37M | -x |
| Atossa Therapeutics, Inc. | ATOS | ██% | $43M | -x |
| Avenue Therapeutics, Inc. | ATXI | ██% | $730K | -x |
| Astria Therapeutics, Inc. | ATXS | ██% | $710M | -4.7x |
| Aurinia Pharmaceuticals Inc. | AUPH | ██% | $1.99B | 6.7x |
| Arrivent Biopharma, Inc. | AVBP | ██% | $1.21B | -x |
| Avadel Pharmaceuticals Plc | AVDL | ██% | $2.10B | -10.2x |
| Atea Pharmaceuticals, Inc. | AVIR | ██% | $354M | -x |
| Avalo Therapeutics, Inc. | AVTX | ██% | $859M | -x |
| Axim Biotechnologies, Inc. | AXIM | ██% | $2M | -x |
| Axsome Therapeutics, Inc. | AXSM | ██% | $12.13B | -x |
| Aytu Biopharma, Inc | AYTU | ██% | $27M | -0.3x |
| Azitra, Inc. | AZTR | ██% | $3M | -x |
| Bridgebio Pharma, Inc. | BBIO | ██% | $13.53B | -x |
| Bridgebio Oncology Therapeutics, … | BBOT | ██% | $685M | -x |
| Bicara Therapeutics Inc. | BCAX | ██% | $1.42B | -x |
| Briacell Therapeutics Corp. | BCTX | ██% | $25M | -x |
| Bicycle Therapeutics Plc | BCYC | ██% | $317M | -x |
| Bioadaptives, Inc. | BDPT | ██% | $130K | -x |
| Biodexa Pharmaceuticals Plc | BDRX | ██% | $510K | -x |
| Beone Medicines Ltd. | BEIGF | ██% | $36.38B | 530.6x |
| Bullfrog Ai Holdings, … | BFRG | ██% | $12M | -x |
| Biofrontera Inc. | BFRI | ██% | $10M | -x |
| Bio Green Med … | BGMS | ██% | $5M | -x |
| Bausch Health Companies … | BHC | ██% | $2.04B | -x |
| Bioharvest Sciences Inc. | BHST | ██% | $87M | -x |
| Biohaven Ltd. | BHVN | ██% | $1.22B | -4.6x |
| Bioage Labs, Inc. | BIOA | ██% | $737M | -x |
| Bio Essence Corp | BIOE | ██% | $13M | 9.8x |
| Biovie Inc. | BIVI | ██% | $11M | -x |
| Bioxytran, Inc | BIXT | ██% | $4M | -x |
| Biolinerx Ltd. | BLRX | ██% | $14M | -x |
| Belite Bio, Inc | BLTE | ██% | $5.40B | -x |
| Biomea Fusion, Inc. | BMEA | ██% | $103M | -x |
| Biomarin Pharmaceutical Inc | BMRN | ██% | $10.45B | 38.9x |
| Bristol Myers Squibb … | BMY | ██% | $121.18B | 16.7x |
| Bristol Myers Squibb … | BMYMP | ██% | $1.73T | 287.0x |
| Benitec Biopharma Inc. | BNTC | ██% | $386M | -x |
| Boundless Bio, Inc. | BOLD | ██% | $32M | -x |
| Bolt Biotherapeutics, Inc. | BOLT | ██% | $10M | -x |
| Bio-Path Holdings, Inc. | BPTH | ██% | $330K | -x |
| Bioquest Corp | BQST | ██% | $2M | -x |
| Barinthus Biotherapeutics Plc. | BRNS | ██% | $28M | -x |
| Bespoke Extracts, Inc. | BSPK | ██% | $2M | -x |
| Bioxcel Therapeutics, Inc. | BTAI | ██% | $35M | -x |
| Beyondspring Inc. | BYSI | ██% | $65M | -x |
| Calcimedica, Inc. | CALC | ██% | $10M | -x |
| Camp4 Therapeutics Corp | CAMP | ██% | $208M | -0.1x |
| Can-Fite Biopharma Ltd. | CANF | ██% | $7M | -x |
| Capricor Therapeutics, Inc. | CAPR | ██% | $1.66B | -x |
| Carisma Therapeutics Inc. | CARM | ██% | $0.00M | 0.0x |
| Casi Pharmaceuticals, Inc. | CASI | ██% | $5M | -1.4x |
| Perspective Therapeutics, Inc. | CATX | ██% | $454M | -x |
| Gyre Therapeutics, Inc. | CBIO | ██% | $572M | -x |
| Cdt Equity Inc. | CDT | ██% | $5M | -x |
| Cingulate Inc. | CING | ██% | $59M | -x |
| Cell Source, Inc. | CLCS | ██% | $56M | -x |
| Clene Inc. | CLNN | ██% | $79M | -x |
| Cellectar Biosciences, Inc. | CLRB | ██% | $26M | -x |
| Clearside Biomedical, Inc. | CLSD | ██% | $4M | -2.0x |
| Clearside Biomedical, Inc. | CLSDQ | ██% | $2M | -x |
| Climb Bio, Inc. | CLYM | ██% | $630M | -x |
| Chemomab Therapeutics Ltd. | CMMB | ██% | $15M | -x |
| Clearmind Medicine Inc. | CMND | ██% | $2M | -x |
| Compass Pathways Plc | CMPS | ██% | $1.59B | -x |
| Cnbx Pharmaceuticals Inc. | CNBX | ██% | $110K | -x |
| Cns Pharmaceuticals, Inc. | CNSP | ██% | $8M | -x |
| Centessa Pharmaceuticals Plc | CNTA | ██% | $6.15B | -x |
| Connect Biopharma Holdings … | CNTB | ██% | $133M | -x |
| Canton Strategic Holdings, … | CNTN | ██% | $246M | -x |
| Context Therapeutics Inc. | CNTX | ██% | $239M | -x |
| Cocrystal Pharma, Inc. | COCP | ██% | $16M | -x |
| Cogent Biosciences, Inc. | COGT | ██% | $5.58B | -x |
| Collegium Pharmaceutical, Inc | COLL | ██% | $1.10B | 14.7x |
| Corcept Therapeutics Inc | CORT | ██% | $6.29B | 132.8x |
| Coya Therapeutics, Inc. | COYA | ██% | $113M | -x |
| China Pharma Holdings, … | CPHI | ██% | $31M | -x |
| Cumberland Pharmaceuticals Inc | CPIX | ██% | $88M | -x |
| Cannapharmarx, Inc. | CPMD | ██% | $3M | -x |
| Catalyst Pharmaceuticals, Inc. | CPRX | ██% | $3.82B | 17.3x |
| Corbus Pharmaceuticals Holdings, … | CRBP | ██% | $201M | -x |
| Cormedix Inc. | CRMD | ██% | $626M | 3.5x |
| Crinetics Pharmaceuticals, Inc. | CRNX | ██% | $3.88B | -x |
| Cervomed Inc. | CRVO | ██% | $28M | -x |
| Corvus Pharmaceuticals, Inc. | CRVS | ██% | $1.06B | -x |
| Cytomx Therapeutics, Inc. | CTMX | ██% | $819M | -x |
| Contineum Therapeutics, Inc. | CTNM | ██% | $518M | -x |
| Citius Oncology, Inc. | CTOR | ██% | $78M | -x |
| Hepion Pharmaceuticals, Inc. | CTRVP | ██% | $20K | -x |
| Ctt Pharmaceutical Holdings, … | CTTH | ██% | $5M | -x |
| Citius Pharmaceuticals, Inc. | CTXR | ██% | $19M | -x |
| Cue Biopharma, Inc. | CUE | ██% | $87M | -x |
| Curanex Pharmaceuticals Inc | CURX | ██% | $9M | -x |
| Cadrenal Therapeutics, Inc. | CVKD | ██% | $16M | -x |
| Cv Sciences, Inc. | CVSI | ██% | $6M | -x |
| Cyclerion Therapeutics, Inc. | CYCN | ██% | $13M | -x |
| Cytodyn Inc. | CYDY | ██% | $460M | -x |
| Cypherpunk Technologies Inc. | CYPH | ██% | $128M | -x |
| Cryoport, Inc. | CYRX | ██% | $703M | 8.8x |
| Cytokinetics Inc | CYTK | ██% | $10.45B | -x |
| Dare Bioscience, Inc. | DARE | ██% | $35M | -x |
| Day One Biopharmaceuticals, … | DAWN | ██% | $2.22B | -x |
| Decoy Therapeutics Inc. | DCOY | ██% | $4M | -x |
| Journey Medical Corp | DERM | ██% | $163M | -x |
| Diamedica Therapeutics Inc. | DMAC | ██% | $318M | -x |
| Damora Therapeutics, Inc. | DMRA | ██% | $1.56B | -x |
| Dianthus Therapeutics, Inc. … | DNTH | ██% | $4.72B | -x |
| Dermata Therapeutics, Inc. | DRMA | ██% | $5M | -x |
| Bright Minds Biosciences … | DRUG | ██% | $817M | -x |
| Design Therapeutics, Inc. | DSGN | ██% | $685M | -x |
| Dynavax Technologies Corp | DVAX | ██% | $1.82B | 88.2x |
| Dogwood Therapeutics, Inc. | DWTX | ██% | $60M | -x |
| Dyne Therapeutics, Inc. | DYN | ██% | $2.87B | -x |
| Emergent Biosolutions Inc. | EBS | ██% | $438M | -x |
| Edesa Biotech, Inc. | EDSA | ██% | $93M | -x |
| Eagle Pharmaceuticals, Inc. | EGRX | ██% | $4M | 0.4x |
| Pmgc Holdings Inc. | ELAB | ██% | $8M | -x |
| Elanco Animal Health … | ELAN | ██% | $10.85B | -x |
| Eledon Pharmaceuticals, Inc. | ELDN | ██% | $295M | -x |
| Elite Pharmaceuticals Inc … | ELTP | ██% | $371M | 13.6x |
| Elicio Therapeutics, Inc. | ELTX | ██% | $185M | -x |
| Enliven Therapeutics, Inc. | ELVN | ██% | $2.53B | -x |
| Emmaus Life Sciences, … | EMMA | ██% | $680K | -x |
| Enlivex Ltd. | ENLV | ██% | $173M | 0.1x |
| Ensysce Biosciences, Inc. | ENSC | ██% | $5M | -x |
| Enanta Pharmaceuticals Inc | ENTA | ██% | $405M | -x |
| Gridai Technologies Corp. | ENTO | ██% | $7M | 0.0x |
| Enveric Biosciences, Inc. | ENVB | ██% | $8M | -x |
| Evolus, Inc. | EOLS | ██% | $401M | -x |
| Essa Pharma Inc. | EPIX | ██% | $9M | -2.7x |
| Eupraxia Pharmaceuticals Inc. | EPRX | ██% | $464M | -x |
| Equillium, Inc. | EQ | ██% | $143M | -x |
| Erasca, Inc. | ERAS | ██% | $3.49B | -x |
| Ernexa Therapeutics Inc. | ERNA | ██% | $14M | -x |
| Esperion Therapeutics, Inc. | ESPR | ██% | $787M | -x |
| 89bio, Inc. | ETNB | ██% | $2.20B | -3.5x |
| Eton Pharmaceuticals, Inc. | ETON | ██% | $892M | -x |
| Earth Science Tech, … | ETST | ██% | $48M | 11.8x |
| Evofem Biosciences, Inc. | EVFM | ██% | $980K | -x |
| Evommune, Inc. | EVMN | ██% | $824M | -x |
| Edgewise Therapeutics, Inc. | EWTX | ██% | $3.51B | -x |
| Fuss Brands Corp. | FBDS | ██% | $2M | -x |
| Fortress Biotech, Inc. | FBIO | ██% | $91M | 0.7x |
| Fortress Biotech, Inc. | FBIOP | ██% | $394M | 98.8x |
| Fibrobiologics, Inc. | FBLG | ██% | $5M | -x |
| Forte Biosciences, Inc. | FBRX | ██% | $442M | -x |
| Fibrogen Inc | FGEN | ██% | $35M | 0.2x |
| Foghorn Therapeutics Inc. | FHTX | ██% | $248M | -x |
| Filana Therapeutics, Inc. | FLNA | ██% | $63M | -x |
| Amicus Therapeutics, Inc. | FOLD | ██% | $4.50B | -x |
| Fulcrum Therapeutics, Inc. | FULC | ██% | $438M | -x |
| Galectin Therapeutics Inc | GALT | ██% | $165M | -x |
| Gain Therapeutics, Inc. | GANX | ██% | $76M | -x |
| Generation Bio Co. | GBIO | ██% | $36M | -0.6x |
| Greater Cannabis Company, … | GCAN | ██% | $140K | -x |
| Cytomed Therapeutics Ltd | GDTC | ██% | $13M | -x |
| Geron Corp | GERN | ██% | $835M | -x |
| Gh Research Plc | GHRS | ██% | $1.37B | -x |
| Galmed Pharmaceuticals Ltd. | GLMD | ██% | $4M | -x |
| Lakefront Biotherapeutics Nv | GLPG | ██% | $1.85B | -x |
| Greenwich Lifesciences, Inc. | GLSI | ██% | $381M | -x |
| Galecto, Inc. | GLTO | ██% | $1.59B | -2.5x |
| Genelux Corp | GNLX | ██% | $131M | -x |
| Genprex, Inc. | GNPX | ██% | $9M | -x |
| Gossamer Bio, Inc. | GOSS | ██% | $49M | -x |
| Geovax Labs, Inc. | GOVX | ██% | $13M | -x |
| Structure Therapeutics Inc. | GPCR | ██% | $2.79B | -x |
| Grace Therapeutics, Inc. | GRCE | ██% | $34M | -x |
| Gridai Technologies Corp. | GRDX | ██% | $30M | -x |
| Gri Bio, Inc. | GRI | ██% | $4M | -x |
| Galera Therapeutics, Inc. | GRTX | ██% | $16M | 0.1x |
| Gsk Plc | GSK | ██% | $103.10B | -x |
| Gt Biopharma, Inc. | GTBP | ██% | $16M | -x |
| Gyre Therapeutics, Inc. | GYRE | ██% | $554M | -x |
| Hutchmed (China) Ltd | HCM | ██% | $2.06B | 2.3x |
| Hcw Biologics Inc. | HCWB | ██% | $19M | -x |
| Cybin Inc. | HELP | ██% | $234M | -x |
| Hepion Pharmaceuticals, Inc. | HEPA | ██% | $3M | -x |
| Vyome Holdings, Inc | HIND | ██% | $16M | -x |
| Hutchmed (China) Ltd | HMDCF | ██% | $2.64B | -x |
| Hookipa Pharma Inc. | HOOK | ██% | $14M | -x |
| Hoth Therapeutics, Inc. | HOTH | ██% | $13M | -x |
| Werewolf Therapeutics, Inc. | HOWL | ██% | $22M | -x |
| Harmony Biosciences Holdings, … | HRMY | ██% | $1.74B | 12.0x |
| Heron Therapeutics, Inc. … | HRTX | ██% | $163M | -x |
| Hst Global, Inc. | HSTC | ██% | $117M | -x |
| Tuhura Biosciences, Inc./Nv | HURA | ██% | $159M | -x |
| Mindwalk Holdings Corp. | HYFT | ██% | $80M | -x |
| Hyperion Defi, Inc. | HYPD | ██% | $55M | -x |
| Ibio, Inc. | IBIO | ██% | $91M | -x |
| Impact Biomedical Inc. | IBO | ██% | $59M | -x |
| Ideaya Biosciences, Inc. | IDYA | ██% | $2.56B | -x |
| Inflarx N.V. | IFRX | ██% | $384M | -x |
| Igc Pharma, Inc. | IGC | ██% | $29M | -x |
| Immutep Ltd | IMMP | ██% | $72M | -x |
| Immix Biopharma, Inc. | IMMX | ██% | $625M | -x |
| Immunome Inc. | IMNM | ██% | $2.45B | -x |
| Imunon, Inc. | IMNN | ██% | $9M | -x |
| Immuron Ltd | IMRN | ██% | $8M | -x |
| Immuneering Corp | IMRX | ██% | $349M | -x |
| Eom Pharmaceutical Holdings, … | IMUC | ██% | $6M | -x |
| Immunic, Inc. | IMUX | ██% | $178M | -x |
| Integrated Biopharma Inc | INBP | ██% | $6M | -x |
| Indaptus Therapeutics, Inc. | INDP | ██% | $138M | -x |
| Indivior Pharmaceuticals, Inc. | INDV | ██% | $4.65B | 18.5x |
| Inmed Pharmaceuticals Inc. | INM | ██% | $6M | -x |
| Inovio Pharmaceuticals, Inc. | INO | ██% | $111M | -x |
| Insmed Inc | INSM | ██% | $23.00B | -x |
| Inhibitor Therapeutics, Inc. | INTI | ██% | $14M | -x |
| Innoviva, Inc. | INVA | ██% | $1.66B | 3.3x |
| Io Biotech, Inc. | IOBT | ██% | $540K | -x |
| Io Biotech, Inc. | IOBTQ | ██% | $210K | -x |
| Ionis Pharmaceuticals Inc | IONS | ██% | $12.54B | -x |
| Opus Genetics, Inc. | IRD | ██% | $347M | -x |
| Disc Medicine, Inc. | IRON | ██% | $2.55B | -x |
| Ironwood Pharmaceuticals Inc | IRWD | ██% | $645M | 6.3x |
| International Stem Cell … | ISCO | ██% | $1M | -x |
| Iterum Therapeutics Plc | ITRM | ██% | $1M | -x |
| Inventiva S.A. | IVA | ██% | $1.06B | -x |
| Incannex Healthcare Inc. | IXHL | ██% | $42M | -x |
| Jaguar Health, Inc. | JAGX | ██% | $2M | -x |
| Janux Therapeutics, Inc. | JANX | ██% | $884M | -x |
| Jazz Pharmaceuticals Plc | JAZZ | ██% | $14.85B | 503.4x |
| Jade Biosciences, Inc. | JBIO | ██% | $1.10B | -x |
| Johnson & Johnson | JNJ | ██% | $564.45B | 26.8x |
| Jupiter Neurosciences, Inc. | JUNS | ██% | $10M | -x |
| Kala Bio, Inc. | KALA | ██% | $45M | -x |
| Kalvista Pharmaceuticals, Inc. | KALV | ██% | $1.37B | -x |
| Kairos Pharma, Ltd. | KAPA | ██% | $12M | -x |
| Kaya Holdings, Inc. | KAYS | ██% | $6M | -x |
| Kamada Ltd | KMDA | ██% | $452M | -x |
| Kiniksa Pharmaceuticals International, … | KNSA | ██% | $4.07B | 55.8x |
| Kiora Pharmaceuticals Inc | KPRX | ██% | $7M | -2.4x |
| Karyopharm Therapeutics Inc. | KPTI | ██% | $184M | -x |
| Keros Therapeutics, Inc. | KROS | ██% | $221M | -x |
| Korro Bio, Inc. | KRRO | ██% | $167M | -x |
| Pasithea Therapeutics Corp. | KTTA | ██% | $23M | -x |
| Kura Oncology, Inc. | KURA | ██% | $999M | -x |
| Kyntra Bio, Inc. | KYNB | ██% | $28M | 0.2x |
| Kezar Life Sciences, … | KZR | ██% | $54M | -x |
| Lb Pharmaceuticals Inc | LBRX | ██% | $806M | -x |
| Legend Biotech Corp | LEGN | ██% | $5.46B | -x |
| Lexaria Bioscience Corp. | LEXX | ██% | $16M | -x |
| Lifecore Biomedical, Inc. … | LFCR | ██% | $185M | -x |
| Lifevantage Corp | LFVN | ██% | $71M | 9.0x |
| Ligand Pharmaceuticals Inc | LGND | ██% | $4.59B | 29.9x |
| Longeveron Inc. | LGVN | ██% | $26M | -x |
| Lianbio | LIANY | ██% | $12M | -x |
| Lftd Partners Inc. | LIFD | ██% | $3M | -x |
| Lipella Pharmaceuticals Inc. | LIPO | ██% | $460K | -x |
| Lite Strategy, Inc. | LITS | ██% | $38M | -x |
| Lixte Biotechnology Holdings, … | LIXT | ██% | $73M | -x |
| Lixte Biotechnology Holdings, … | LIXTW | ██% | $130K | -x |
| Lakefront Biotherapeutics Nv | LKFT | ██% | $1.81B | -x |
| Eli Lilly & … | LLY | ██% | $952.64B | 37.7x |
| Lunai Bioworks Inc. | LNAI | ██% | $10M | -x |
| Lipocine Inc. | LPCN | ██% | $17M | -x |
| Cypherpunk Technologies Inc. | LPTX | ██% | $94M | -1.1x |
| Liquidia Corp | LQDA | ██% | $5.39B | 241.4x |
| Larimar Therapeutics, Inc. | LRMR | ██% | $358M | -x |
| Lisata Therapeutics, Inc. | LSTA | ██% | $29M | -x |
| Lantern Pharma Inc. | LTRN | ██% | $45M | -x |
| Lava Therapeutics Nv | LVTX | ██% | $46M | -x |
| Lexicon Pharmaceuticals, Inc. | LXRX | ██% | $920M | -x |
| Lyell Immunopharma, Inc. | LYEL | ██% | $407M | -x |
| Maia Biotechnology, Inc. | MAIA | ██% | $78M | -x |
| Mustang Bio, Inc. | MBIO | ██% | $5M | -x |
| Moleculin Biotech, Inc. | MBRX | ██% | $13M | -x |
| Mbx Biosciences, Inc. | MBX | ██% | $1.52B | -x |
| Seres Therapeutics, Inc. | MCRB | ██% | $76M | -x |
| Medicus Pharma Ltd. | MDCX | ██% | $17M | -x |
| Medicus Pharma Ltd. | MDCXW | ██% | $52M | -x |
| Madrigal Pharmaceuticals, Inc. | MDGL | ██% | $11.92B | -x |
| Chrome Holding Co. | MEHCQ | ██% | $96M | -x |
| Macrogenics Inc | MGNX | ██% | $288M | -x |
| Mira Pharmaceuticals, Inc. | MIRA | ██% | $42M | -x |
| Mirum Pharmaceuticals, Inc. | MIRM | ██% | $6.01B | -x |
| Milestone Pharmaceuticals Inc. | MIST | ██% | $166M | -x |
| Moonlake Immunotherapeutics | MLTX | ██% | $1.30B | -x |
| Mineralys Therapeutics, Inc. | MLYS | ██% | $2.46B | -x |
| Mannkind Corp | MNKD | ██% | $1.04B | -x |
| Medicinova Inc | MNOV | ██% | $69M | -x |
| Monopar Therapeutics | MNPR | ██% | $423M | -x |
| Maplight Therapeutics, Inc. | MPLT | ██% | $1.30B | -x |
| Mereo Biopharma Group … | MREO | ██% | $44M | -x |
| Merck & Co., … | MRK | ██% | $302.60B | 33.9x |
| Marker Therapeutics, Inc. | MRKR | ██% | $23M | -x |
| Mersana Therapeutics, Inc. | MRSN | ██% | $145M | -3.4x |
| Merus N.V. | MRUS | ██% | $6.83B | -13.5x |
| Maravai Lifesciences Holdings, … | MRVI | ██% | $1.62B | -x |
| Matinas Biopharma Holdings, … | MTNB | ██% | $5M | -x |
| Metsera, Inc. | MTSR | ██% | $7.41B | -x |
| Metavia Inc. | MTVA | ██% | $20M | -x |
| Mural Oncology Plc | MURA | ██% | $35M | -x |
| Mainz Biomed N.V. | MYNZ | ██% | $7M | -x |
| Newamsterdam Pharma Co … | NAMS | ██% | $4.13B | -x |
| Newamsterdam Pharma Co … | NAMSW | ██% | $2.59B | -x |
| Natures Sunshine Products … | NATR | ██% | $384M | 19.3x |
| Novabridge Biosciences | NBP | ██% | $205M | -x |
| Nanobiotix S.A. | NBTX | ██% | $1.49B | -x |
| Stablecoin Development Corp | NBY | ██% | $37M | -x |
| Newcelx Ltd. | NCEL | ██% | $17M | -x |
| Nucana Plc | NCNA | ██% | $8M | -x |
| Minerva Neurosciences, Inc. | NERV | ██% | $231M | -x |
| Neuphoria Therapeutics Inc. | NEUP | ██% | $29M | -x |
| Neurogene Inc. | NGNE | ██% | $433M | -x |
| Nika Pharmaceuticals, Inc | NIKA | ██% | $535M | -x |
| Nektar Therapeutics | NKTR | ██% | $2.25B | -x |
| Nkarta, Inc. | NKTX | ██% | $225M | -x |
| Newcelx Ltd. | NLSP | ██% | $54M | -x |
| Newcelx Ltd. | NLSPW | ██% | $120K | -x |
| Nanoviricides, Inc. | NNVC | ██% | $36M | -x |
| Nurix Therapeutics, Inc. | NRIX | ██% | $1.81B | -x |
| Neurosense Therapeutics Ltd. | NRSN | ██% | $30M | -x |
| Nrx Pharmaceuticals, Inc. | NRXP | ██% | $108M | -x |
| Neonc Technologies Holdings, … | NTHI | ██% | $133M | -x |
| Nuvation Bio Inc. | NUVB | ██% | $1.64B | -x |
| Nuvalent, Inc. | NUVL | ██% | $8.03B | -x |
| Nuvectis Pharma, Inc. | NVCT | ██% | $275M | -x |
| Novartis Ag | NVS | ██% | $290.06B | -x |
| Northwest Biotherapeutics Inc | NWBO | ██% | $370M | -x |
| Nexien Biopharma, Inc. | NXEN | ██% | $10K | -x |
| Nextcure, Inc. | NXTC | ██% | $28M | -x |
| Nexentis Technologies Inc. | NXTS | ██% | $3M | -x |
| Ocean Biomedical, Inc. | OCEA | ██% | $190K | -0.3x |
| Ocular Therapeutix, Inc | OCUL | ██% | $1.80B | -x |
| Oragenics Inc | OGEN | ██% | $3M | -x |
| Organigram Global Inc. | OGI | ██% | $158M | -x |
| Organon & Co. | OGN | ██% | $3.53B | 14.3x |
| Onkure Therapeutics, Inc. | OKUR | ██% | $170M | -x |
| Olema Pharmaceuticals, Inc. | OLMA | ██% | $1.19B | -x |
| Omeros Corp | OMER | ██% | $825M | 9.6x |
| Beone Medicines Ltd. | ONC | ██% | $32.19B | 62.7x |
| Onconetix, Inc. | ONCO | ██% | $1M | -x |
| Oncolytics Biotech Inc | ONCY | ██% | $94M | -x |
| Opko Health, Inc. | OPK | ██% | $964M | -x |
| Organogenesis Holdings Inc. | ORGO | ██% | $342M | 125.9x |
| Orgenesis Inc. | ORGS | ██% | $3M | -x |
| Oric Pharmaceuticals, Inc. | ORIC | ██% | $861M | -x |
| Oruka Therapeutics, Inc. | ORKA | ██% | $3.66B | -x |
| Oramed Pharmaceuticals Inc. | ORMP | ██% | $163M | 1.5x |
| Os Therapies Inc | OSTX | ██% | $77M | -x |
| Oncotelic Therapeutics, Inc. | OTLC | ██% | $27M | -x |
| Ovid Therapeutics Inc. | OVID | ██% | $461M | -x |
| One World Products, … | OWPC | ██% | $630K | -x |
| Phibro Animal Health … | PAHC | ██% | $1.35B | 14.2x |
| Prestige Consumer Healthcare … | PBH | ██% | $2.33B | 12.2x |
| Psyence Biomedical Ltd. | PBM | ██% | $9M | -x |
| Puma Biotechnology, Inc. | PBYI | ██% | $360M | 14.8x |
| Pacira Biosciences, Inc. | PCRX | ██% | $918M | 178.7x |
| Processa Pharmaceuticals, Inc. | PCSA | ██% | $7M | -x |
| Procyon Corp | PCYN | ██% | $2M | -x |
| Pds Biotechnology Corp | PDSB | ██% | $67M | -x |
| Pepgen Inc. | PEPG | ██% | $104M | -x |
| Pfizer Inc | PFE | ██% | $147.40B | 19.7x |
| Precigen, Inc. | PGEN | ██% | $1.51B | -x |
| Phathom Pharmaceuticals, Inc. | PHAT | ██% | $900M | -x |
| Phio Pharmaceuticals Corp. | PHIO | ██% | $13M | -x |
| Pharvaris N.V. | PHVS | ██% | $2.07B | -x |
| Protokinetix, Inc. | PKTX | ██% | $3M | -x |
| Plandai Biotechnology, Inc. | PLPL | ██% | $4M | -x |
| Pliant Therapeutics, Inc. | PLRX | ██% | $75M | -x |
| Polomar Health Services, … | PMHS | ██% | $4M | -x |
| Promis Neurosciences Inc. | PMN | ██% | $98M | -x |
| Pmv Pharmaceuticals, Inc. | PMVP | ██% | $67M | -x |
| Purple Biotech Ltd. | PPBT | ██% | $4M | -x |
| Propanc Biopharma, Inc. | PPCB | ██% | $4M | -x |
| Praxis Precision Medicines, … | PRAX | ██% | $9.57B | -x |
| Prf Technologies Ltd. | PRFX | ██% | $1M | -x |
| Perrigo Co Plc | PRGO | ██% | $1.55B | -x |
| Prelude Therapeutics Inc | PRLD | ██% | $352M | -x |
| Prophase Labs, Inc. | PRPH | ██% | $520K | -x |
| Proqr Therapeutics N.V. | PRQR | ██% | $164M | -x |
| Prothena Corp Public … | PRTA | ██% | $522M | -x |
| Ptc Therapeutics, Inc. | PTCT | ██% | $5.70B | -x |
| Protagonist Therapeutics, Inc | PTGX | ██% | $6.37B | -x |
| Protagenic Therapeutics, Inc.\New | PTIX | ██% | $1M | -x |
| Palatin Technologies Inc | PTN | ██% | $26M | -x |
| Palatin Technologies Inc | PTNT | ██% | $17M | -x |
| Petros Pharmaceuticals, Inc. | PTPI | ██% | $250K | 0.1x |
| Pulmatrix, Inc. | PULM | ██% | $5M | -x |
| Provectus Biopharmaceuticals, Inc. | PVCT | ██% | $27M | -x |
| Palvella Therapeutics, Inc. | PVLA | ██% | $1.63B | -x |
| Pyxis Oncology, Inc. | PYXS | ██% | $123M | -x |
| Aixcrypto Holdings, Inc. | QLGN | ██% | $8M | -1.3x |
| Quoin Pharmaceuticals, Ltd. | QNRX | ██% | $10M | -x |
| Quantum Biopharma Ltd. | QNTM | ██% | $59M | -x |
| Q32 Bio Inc. | QTTB | ██% | $98M | 3.0x |
| Quantum Cyber N.V. | QUCY | ██% | $49M | -x |
| Uniqure N.V. | QURE | ██% | $1.52B | -x |
| Radiopharm Theranostics Ltd | RADX | ██% | $36M | -x |
| Rani Therapeutics Holdings, … | RANI | ██% | $134M | -x |
| Rapport Therapeutics, Inc. | RAPP | ██% | $1.80B | -x |
| Rapt Therapeutics, Inc. | RAPT | ██% | $1.56B | -0.4x |
| Ultragenyx Pharmaceutical Inc. | RARE | ██% | $2.30B | -x |
| Rocket Pharmaceuticals, Inc. | RCKT | ██% | $323M | -x |
| Arcus Biosciences, Inc. | RCUS | ██% | $2.94B | -x |
| Dr Reddys Laboratories … | RDY | ██% | $11.35B | -x |
| Regeneron Pharmaceuticals, Inc. | REGN | ██% | $66.44B | 15.0x |
| Revelation Biosciences, Inc. | REVB | ██% | $4M | -x |
| Rafael Holdings, Inc. | RFL | ██% | $69M | -x |
| Regen Biopharma Inc | RGBP | ██% | $180K | -x |
| Regen Biopharma Inc | RGBPP | ██% | $470K | -x |
| Rigel Pharmaceuticals Inc | RIGL | ██% | $534M | 1.5x |
| Relmada Therapeutics, Inc. | RLMD | ██% | $738M | -x |
| Rallybio Corp | RLYB | ██% | $84M | -x |
| Retrieve Medical Holdings, … | RMHI | ██% | $18M | -x |
| Rockwell Medical, Inc. | RMTI | ██% | $31M | -x |
| Avidity Biosciences, Inc. | RNA | ██% | $206M | -12.2x |
| Cartesian Therapeutics, Inc. | RNAC | ██% | $193M | -x |
| Transcode Therapeutics, Inc. | RNAZ | ██% | $6M | -x |
| Rein Therapeutics, Inc. | RNTX | ██% | $88M | -x |
| Renovorx, Inc. | RNXT | ██% | $40M | -x |
| Roivant Sciences Ltd. | ROIV | ██% | $21.58B | -x |
| Royalty Pharma Plc | RPRX | ██% | $31.38B | 37.9x |
| Repare Therapeutics Inc. | RPTX | ██% | $114M | -2.1x |
| Rest Ez Inc. | RTEZ | ██% | $1.93B | -x |
| Rapid Therapeutic Science … | RTSL | ██% | $110K | 1.9x |
| Reviva Pharmaceuticals Holdings, … | RVPH | ██% | $5M | -x |
| Rhythm Pharmaceuticals, Inc. | RYTM | ██% | $6.01B | -x |
| Rezolute, Inc. | RZLT | ██% | $313M | -x |
| Filana Therapeutics, Inc. | SAVA | ██% | $101M | -1.9x |
| Sunshine Biopharma Inc. | SBFM | ██% | $2M | -x |
| Scienture Holdings, Inc. | SCNX | ██% | $16M | -x |
| Scpharmaceuticals Inc. | SCPH | ██% | $302M | -2.0x |
| Scorpius Holdings, Inc. | SCPX | ██% | $610K | -x |
| Scynexis Inc | SCYX | ██% | $58M | -x |
| Stablecoin Development Corp | SDEV | ██% | $38M | 0.1x |
| Schrodinger, Inc. | SDGR | ██% | $984M | -x |
| Septerna, Inc. | SEPN | ██% | $1.27B | -x |
| Serina Therapeutics, Inc. | SER | ██% | $30M | -x |
| Sagimet Biosciences Inc. | SGMT | ██% | $438M | -x |
| Shuttle Pharmaceuticals Holdings, … | SHPH | ██% | $3M | -x |
| Siga Technologies Inc | SIGA | ██% | $336M | 16.6x |
| Silo Pharma, Inc. | SILO | ██% | $6M | -x |
| Sionna Therapeutics, Inc. | SION | ██% | $1.85B | -x |
| Skinvisible, Inc. | SKVI | ██% | $920K | -x |
| Skye Bioscience, Inc. | SKYE | ██% | $29M | -x |
| Sol-Gel Technologies Ltd. | SLGL | ██% | $249M | -x |
| Silence Therapeutics Plc | SLN | ██% | $293M | -x |
| Silence Therapeutics Plc | SLNCF | ██% | $213M | -x |
| Soleno Therapeutics Inc | SLNO | ██% | $2.74B | 28.6x |
| Salarius Pharmaceuticals, Inc. | SLRX | ██% | $2M | -0.5x |
| Sellas Life Sciences … | SLS | ██% | $1.41B | -x |
| Summit Therapeutics Inc. | SMMT | ██% | $12.90B | -x |
| Semnur Pharmaceuticals, Inc. | SMNR | ██% | $1.15B | -x |
| Syndax Pharmaceuticals Inc | SNDX | ██% | $1.77B | -x |
| Soligenix, Inc. | SNGX | ██% | $6M | -x |
| Sibannac, Inc. | SNNC | ██% | $2M | -x |
| Sensei Biotherapeutics, Inc. | SNSE | ██% | $24M | -x |
| Sanofi | SNY | ██% | $105.85B | -x |
| Sonnet Biotherapeutics Holdings, … | SONN | ██% | $4M | -1.6x |
| Spruce Biosciences, Inc. | SPRB | ██% | $141M | -x |
| Scisparc Ltd. | SPRC | ██% | $2M | -x |
| Spero Therapeutics, Inc. | SPRO | ██% | $160M | 10.5x |
| Ars Pharmaceuticals, Inc. | SPRY | ██% | $788M | -x |
| Sarepta Therapeutics, Inc. | SRPT | ██% | $1.77B | 27.3x |
| Stoke Therapeutics, Inc. | STOK | ██% | $1.83B | -x |
| Shattuck Labs, Inc. | STTK | ██% | $461M | -x |
| Supernus Pharmaceuticals, Inc. | SUPN | ██% | $2.80B | -x |
| Savara Inc | SVRA | ██% | $1.03B | -x |
| 60 Degrees Pharmaceuticals, … | SXTP | ██% | $4M | -x |
| Synlogic, Inc. | SYBX | ██% | $8M | -x |
| Spyre Therapeutics, Inc. | SYRE | ██% | $5.84B | -x |
| Syros Pharmaceuticals, Inc. | SYRS | ██% | $20K | -0.1x |
| Takeda Pharmaceutical Co … | TAK | ██% | $51.34B | -x |
| Theravance Biopharma, Inc. | TBPH | ██% | $843M | 7.4x |
| Alaunos Therapeutics, Inc. | TCRT | ██% | $6M | -x |
| Telomir Pharmaceuticals, Inc. | TELO | ██% | $89M | -x |
| Tenax Therapeutics, Inc. | TENX | ██% | $322M | -x |
| Terns Pharmaceuticals, Inc. | TERN | ██% | $6.12B | -x |
| Teva Pharmaceutical Industries … | TEVA | ██% | $39.67B | 25.4x |
| Teva Pharmaceutical Industries … | TEVJF | ██% | $38.09B | 53.4x |
| Tg Therapeutics, Inc. | TGTX | ██% | $5.95B | 12.9x |
| Canton Strategic Holdings, … | THAR | ██% | $186M | -x |
| Talphera, Inc. | TLPH | ██% | $41M | -x |
| Telix Pharmaceuticals Ltd | TLX | ██% | $3.21B | -x |
| Tango Therapeutics, Inc. | TNGX | ██% | $2.92B | -x |
| Tonix Pharmaceuticals Holding … | TNXP | ██% | $204M | -x |
| Theriva Biologics, Inc. | TOVX | ██% | $14M | -x |
| Tempest Therapeutics, Inc. | TPST | ██% | $27M | -x |
| Traws Pharma, Inc. | TRAW | ██% | $17M | -0.6x |
| Entrada Therapeutics, Inc. | TRDA | ██% | $255M | -x |
| Trevi Therapeutics, Inc. | TRVI | ██% | $1.81B | -x |
| Trevena Inc | TRVN | ██% | $260K | -1.3x |
| Turn Therapeutics Inc. | TTRX | ██% | $153M | -x |
| Tvardi Therapeutics, Inc. | TVRD | ██% | $33M | -x |
| Travere Therapeutics, Inc. | TVTX | ██% | $4.11B | -x |
| Therapeuticsmd, Inc. | TXMD | ██% | $25M | 137.1x |
| Tyra Biosciences, Inc. | TYRA | ██% | $1.93B | -x |
| Unicycive Therapeutics, Inc. | UNCY | ██% | $204M | -x |
| Upstream Bio, Inc. | UPB | ██% | $456M | -x |
| Urogen Pharma Ltd. | URGN | ██% | $1.41B | -x |
| United Therapeutics Corp | UTHR | ██% | $23.96B | 18.6x |
| Vaccinex, Inc. | VCNX | ██% | $3M | -x |
| Vera Therapeutics, Inc. | VERA | ██% | $2.43B | -x |
| Veru Inc. | VERU | ██% | $39M | -0.8x |
| Sb Technology Holdings, … | VGLS | ██% | $710K | -x |
| Sb Technology Holdings, … | VGLSD | ██% | $520K | -x |
| Vicapsys Life Sciences, … | VICP | ██% | $47M | -x |
| Vincerx Pharma, Inc. | VINC | ██% | $70K | -0.2x |
| Viracta Therapeutics, Inc. | VIRX | ██% | $390K | -0.2x |
| Viking Therapeutics, Inc. | VKTX | ██% | $3.58B | -x |
| Vanda Pharmaceuticals Inc. | VNDA | ██% | $372M | -x |
| Verrica Pharmaceuticals Inc. | VRCA | ██% | $104M | -x |
| Viridian Therapeutics, Inc.\De | VRDN | ██% | $1.77B | -x |
| Vireo Growth Inc. | VREOF | ██% | $348M | -x |
| Verona Pharma Plc | VRNA | ██% | $73.55B | -185.1x |
| Virpax Pharmaceuticals, Inc. | VRPX | ██% | $160K | 0.0x |
| Vertex Pharmaceuticals Inc … | VRTX | ██% | $110.44B | 25.5x |
| Verastem, Inc. | VSTM | ██% | $372M | -x |
| Vistagen Therapeutics, Inc. | VTGN | ██% | $27M | -x |
| Viatris Inc | VTRS | ██% | $19.24B | -x |
| Vtv Therapeutics Inc. | VTVT | ██% | $0.00M | -3.3x |
| Ventyx Biosciences, Inc. | VTYX | ██% | $999M | -1.0x |
| Vyne Therapeutics Inc. | VYNE | ██% | $22M | -x |
| Whitehawk Therapeutics, Inc. | WHWK | ██% | $212M | -x |
| Wave Life Sciences … | WVE | ██% | $1.23B | -x |
| Xenetic Biosciences, Inc. | XBIO | ██% | $7M | -x |
| Xbiotech Inc. | XBIT | ██% | $74M | -x |
| Exicure, Inc. | XCUR | ██% | $18M | -x |
| Xenon Pharmaceuticals Inc. | XENE | ██% | $5.23B | -x |
| Xeris Biopharma Holdings, … | XERS | ██% | $1.07B | 89.0x |
| Xilio Therapeutics, Inc. | XLO | ██% | $48M | -x |
| Xencor Inc | XNCR | ██% | $838M | -x |
| Xoma Royalty Corp | XOMA | ██% | $496M | 14.7x |
| Xoma Royalty Corp | XOMAO | ██% | $312M | 14.4x |
| Xoma Royalty Corp | XOMAP | ██% | $326M | 15.1x |
| Xtl Biopharmaceuticals Ltd | XTLB | ██% | $6M | -x |
| Zenas Biopharma, Inc. | ZBIO | ██% | $1.18B | -x |
| Zai Lab Ltd | ZLAB | ██% | $2.09B | -x |
| Zentalis Pharmaceuticals, Inc. | ZNTL | ██% | $289M | -x |
| Zomedica Corp. | ZOMDF | ██% | $132M | -x |
| Zoetis Inc. | ZTS | ██% | $34.18B | 12.9x |
| Zevra Therapeutics, Inc. | ZVRA | ██% | $593M | 4.8x |
| Zyversa Therapeutics, Inc. | ZVSA | ██% | $1M | -x |
| Zymeworks Inc. | ZYME | ██% | $1.75B | -8.3x |
よくあるご質問
-
Theravance Biopharma, Inc.は買いの銘柄ですか？
当社のAIはTheravance Biopharma, Inc.を毎日分析しています。上記のシグナルで最新の推奨をご確認ください。投資前には必ずご自身で調査を行ってください。
-
Theravance Biopharma, Inc.の予測精度はどの程度ですか？
当社のAIはこの銘柄で9%のスピアマン相関を達成しており、毎日分析される4,000以上の銘柄で平均67%以上の精度です。
-
予測はどのくらいの頻度で更新されますか？
Theravance Biopharma, Inc.の予測は最新の市場データとAIモデルを使用して毎日更新されます。
Theravance Biopharma, Inc.のより深い分析をお探しですか？
Intratioで機関投資家レベルの完全な分析を表示 →AI予測は過去のパターンに基づいており、投資判断の唯一の根拠とすべきではありません。過去の実績は将来の結果を保証するものではありません。必ずご自身で調査を行ってください。